WallStreetZenWallStreetZen

NASDAQ: MBRX
Moleculin Biotech Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MBRX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$29.8M
Current Profit Margin
0%

MBRX Return on Equity

Current Company
-80.9%
Current Industry
-63.5%
Current Market
188%
MBRX's Return on Equity (-80.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MBRX announces earnings.

MBRX Return on Assets

Current Company
-67.7%
Current Industry
2.9%
MBRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MBRX Return on Capital Employed

Current Company
-94.8%
Current Industry
19.5%
MBRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MBRX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MBRX$0.00-$29.64M-$29.77MN/AN/A
AEZS$4.50M-$16.38M-$16.55M-30.06%N/A
KZIA$15.13kN/A-$10.33M-65.97%N/A
ERNA$68.00k-$19.93M-$21.68M-68.89%N/A
CMMB$0.00-$24.15M-$24.22MN/AN/A
View Top Biotech Stocks

MBRX earnings dates

Next earnings date
May 9, 2024

Moleculin Biotech Earnings & Revenue FAQ

What were MBRX's earnings last quarter?

On Invalid Date, Moleculin Biotech (NASDAQ: MBRX) reported Q4 2023 earnings per share (EPS) of -$5.17, up 46.88% year over year. Total Moleculin Biotech earnings for the quarter were -$10.27 million. In the same quarter last year, Moleculin Biotech's earnings per share (EPS) was -$3.52.

If you're new to stock investing, here's how to buy Moleculin Biotech stock.

What was MBRX's earnings growth in the past year?

As of Q2 2024, Moleculin Biotech's earnings has grown year over year. Moleculin Biotech's earnings in the past year totalled -$29.77 million.

What is MBRX's earnings date?

Moleculin Biotech's earnings date is Invalid Date. Add MBRX to your watchlist to be reminded of MBRX's next earnings announcement.

What was MBRX's revenue last quarter?

On Invalid Date, Moleculin Biotech (NASDAQ: MBRX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Moleculin Biotech's revenue was $0.00.

What was MBRX's revenue growth in the past year?

As of Q2 2024, Moleculin Biotech's revenue has grown null year over year. Moleculin Biotech's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.